Connect Biopharma Holdings Limited (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

Compare

2.700

+0.050 (1.89%)

At close: Feb 11, 2026, 4:00 PM EST

2.680

-0.020 (-0.74%)

After-hours: Feb 11, 2026, 4:10 PM EST

CNTB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	37.85	78.23	105.66	79.01	267.72	154.72
Short-Term Investments	16.94	15.48	12.64	73.46	-	0.59
Trading Asset Securities	-	-	-	-	-	2
Cash & Short-Term Investments	54.78	93.71	118.3	152.47	267.72	157.31
Cash Growth	-	-20.79%	-22.41%	-43.05%	70.18%	218.37%
Accounts Receivable	0.02	0.79	-	-	-	-
Other Receivables	0.16	0.26	0.35	-	7.41	-
Receivables	0.17	1.05	0.35	-	7.41	-
Prepaid Expenses	7.64	2.15	3.85	3.31	-	4.56
Other Current Assets	-	0.05	0.05	-	-	-
Total Current Assets	62.6	96.96	122.55	155.78	275.13	161.87
Property, Plant & Equipment	4.67	4.24	4.74	8.47	12.89	1.21
Long-Term Investments	-	-	-	9.44	-	-
Other Intangible Assets	0.05	0.05	0.06	0.07	0.09	0.05
Other Long-Term Assets	0.05	0.03	0.02	0.25	2.95	3.04
Total Assets	67.36	101.28	127.38	174.01	291.05	166.17
Accounts Payable	1.99	0.34	2.21	11.94	12.74	3.77
Accrued Expenses	8.93	7.8	9.48	2.96	-	1.87
Current Portion of Leases	0.34	0.15	0.29	0.19	0.1	0.09
Current Unearned Revenue	0.17	0.16	13.32	-	-	-
Other Current Liabilities	-	-	-	0.54	5.15	0.08
Total Current Liabilities	11.43	8.46	25.29	15.62	17.99	5.82
Long-Term Debt	-	-	-	-	-	317.3
Long-Term Leases	0.45	0.02	0.18	0.25	0.03	0.05
Long-Term Unearned Revenue	-	-	-	0.65	0.78	-
Other Long-Term Liabilities	0.12	0.63	0.41	-	-	-
Total Liabilities	11.99	9.12	25.88	16.52	18.8	323.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	442.54	439.36	432.4	628.66	628.64	6.35
Retained Earnings	-385.73	-345.36	-329.73	-479.84	-361.75	-164.1
Treasury Stock	-0.18	-0.18	-0.18	-0.18	-0.18	-0
Comprehensive Income & Other	-1.28	-1.67	-1.01	8.85	5.54	0.75
Shareholders' Equity	55.37	92.17	101.5	157.49	272.26	-156.99
Total Liabilities & Equity	67.36	101.28	127.38	174.01	291.05	166.17
Total Debt	0.78	0.18	0.47	0.43	0.13	317.44
Net Cash (Debt)	54	93.53	117.84	152.04	267.59	-160.13
Net Cash Growth	-	-20.63%	-22.49%	-43.18%	-	-
Net Cash Per Share	0.97	1.69	2.14	2.76	5.13	-9.37
Filing Date Shares Outstanding	55.9	55.35	55.1	55.04	55.08	17.09
Total Common Shares Outstanding	55.79	55.35	55.1	55.04	55.08	17.09
Working Capital	51.17	88.5	97.26	140.16	257.14	156.05
Book Value Per Share	0.99	1.67	1.84	2.86	4.94	-9.19
Tangible Book Value	55.32	92.11	101.44	157.42	272.17	-157.05
Tangible Book Value Per Share	0.99	1.66	1.84	2.86	4.94	-9.19
Machinery	-	5.85	5.68	5.84	5.77	0.96
Construction In Progress	-	-	-	-	3.7	0.29
Leasehold Improvements	-	0.83	0.63	0.76	0.73	0.22

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q